Detalhe da pesquisa
1.
Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up.
Int J Cancer
; 150(1): 100-111, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449877
2.
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination.
J Transl Med
; 20(1): 419, 2022 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089578
3.
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613827
4.
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial.
Front Immunol
; 12: 663865, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046035